Cargando…
Re-treatment of Hepatitis C Infection After Multiple Failures of Direct-Acting Antiviral Therapy
BACKGROUND: Direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) result in initial cure rates of 95% to 99% and re-treatment cure rates of 95%. Nevertheless, given the sheer magnitude of infected persons, some will ultimately fail multiple DAA therapies, and re-treatment of these pers...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148001/ https://www.ncbi.nlm.nih.gov/pubmed/32296728 http://dx.doi.org/10.1093/ofid/ofaa095 |